EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure

Clinical guideline · Tier 2, Specialist societies · EU · 2017-05

Current — checked with the publisher on 2026-09-01

https://pubmed.ncbi.nlm.nih.gov/28417882/

What this platform has drawn from it — 1 claim

The EASL guideline on acute liver failure states that liver support systems, biological or adsorbent, should only be used in the context of a randomised controlled trial. Section 'Artificial and bioartificial liver devices', Recommendations box, journal page 1068
read on Extracorporeal liver support

How this record was checked, and what is doubtful about it

Listed by EASL under Clinical Practice Guidelines with no archive or supersession label. EASL does not display an explicit status label, so 'current' here means 'published as a CPG and not marked superseded'.

Verification: verified · last accessed 2026-09-01 · status checked against https://easl.eu/publication/acute-liver-failure-guidelines/